GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YungShin Global Holding Co Ltd (TPE:3705) » Definitions » Valuation Rank

YungShin Global Holding Co (TPE:3705) Valuation Rank


View and export this data going back to 2011. Start your Free Trial

What is YungShin Global Holding Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


YungShin Global Holding Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of YungShin Global Holding Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


YungShin Global Holding Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1191, Zhongshan Road, Section 1, Dajia District, Taichung, TWN
YungShin Global Holding Co Ltd invests, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics. YungShin also provides grants for medical research, operates a nursing home for senior care, promotes healthful lifestyles, and maintains a product range that includes healthy food and beauty care. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities.